During the year, the Pharmacogenomics and Transcriptomics Network organises meetings for its members (also at the annual ECNP Congress).

Clinical, -omics and imaging biomarkers of complex psychiatric disorders summer school
The ECNP Pharmacogenomics and Transcriptomics Network and ECNP Suicide Network have organised a summer school.

  • When
    11-13 September 2024
  • Where
    Bordeaux School of Neuroscience, France

This summer school will focus on the integration of clinical, imaging, and genetics/omics biomarkers to diagnose and improve pharmacological treatment of psychiatric disorders and related conditions including suicidal behaviours. It aims to blend clinical psychiatry with molecular genetics and transcriptomics through theoretical sessions and practical workshops, data management, analysis, and interpretation for psychiatric conditions and traits, including major depression, bipolar disorder, schizophrenia and suicidality.

  • Target audience
    The programme is intended for PhD students, early career to senior scientists, clinician researchers, and other professionals in the field. Please note that a basic understanding of the programming language R (elementary level and above) is recommended.
  • Application requirements
    Application form
    - CV and motivation letter
    - Recommendation (head of department)
  • Deadline
    The application must be send via e-mail by 30 July 2024.
  • Registration fee
    The registration fee for the summer school is EUR 300 per participant (transportation not included).
    For more information, please see the flyer and visit the website.

Research projects

  • PSYCH STRATA — A Stratified Treatment Algorithm in Psychiatry: a programme on stratified pharmacogenomics in severe mental illness (HORIZON HLTH 2021 STAYHLTH 01)
  • PROMPT – Toward PrecisiOn Medicine for the Prediction of Treatment response in major depressive disorder through stratification of combined clinical and -omics signatures (EraPerMed Grant)

Recommended publications

Authors  Year
Journal and link to the article
Minelli et al.  
2022 Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials — challenges and future perspectives. A critical review.
European Neuropsychopharmacology
Pisanu et al.
2022 Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review. 
European Neuropsychopharmacology
Fanelli et al.
2022  A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response
European Neuropsychopharmacology
Xicota et al.
2022 Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders
European Neuropsychopharmacology